Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.

Hu, Jian-li

Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old. [electronic resource] - Human vaccines & immunotherapeutics 2015 - 1120-8 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

2164-554X

10.1080/21645515.2015.1033592 doi


Antibodies, Bacterial--blood
Child, Preschool
China
Drug-Related Side Effects and Adverse Reactions--epidemiology
Female
Haemophilus Infections--prevention & control
Haemophilus Vaccines--administration & dosage
Haemophilus influenzae type b--immunology
Humans
Incidence
Infant
Male
Meningococcal Infections--prevention & control
Meningococcal Vaccines--administration & dosage
Neisseria meningitidis, Serogroup A--immunology
Neisseria meningitidis, Serogroup C--immunology
Tetanus Toxoid--administration & dosage
Vaccines, Combined--administration & dosage
Vaccines, Conjugate--administration & dosage